WHO Recommends Cannabis Rescheduling

By | February 2, 2019

This morning the World Health Organization (WHO) made an announcement that has the potential to change the status of medical cannabis globally. The WHO has determined that cannabis and cannabis resin should be removed from Schedule IV of the Single Convention on Narcotic Drugs (which is different than the U.S. Controlled Substances Act scheduling) and divided into more specific categories in lower schedules. For, example compound pharmaceutical preparations containing THC  would be placed in Schedule III and CBD preparations would be removed from scheduling entirely.

Source: http://www.safeaccessnow.org/who_recommendations

Leave a Reply

Your email address will not be published. Required fields are marked *